[go: up one dir, main page]

WO2011071799A3 - Purification of bivalirudin - Google Patents

Purification of bivalirudin Download PDF

Info

Publication number
WO2011071799A3
WO2011071799A3 PCT/US2010/059045 US2010059045W WO2011071799A3 WO 2011071799 A3 WO2011071799 A3 WO 2011071799A3 US 2010059045 W US2010059045 W US 2010059045W WO 2011071799 A3 WO2011071799 A3 WO 2011071799A3
Authority
WO
WIPO (PCT)
Prior art keywords
bivalirudin
purification
processes
substantially pure
pure bivalirudin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2010/059045
Other languages
French (fr)
Other versions
WO2011071799A2 (en
Inventor
Pratap Reddy Padi
Santhana Krishnan Srinivasan
Venugopal Rao Dama
Basanthi Devi
Chakravarthula Kalyan Narasimham Nalla
Ramesh Bochha
Parameswara Reddy Koche
Yagna Kiran Kumar Komaravolu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2011071799A2 publication Critical patent/WO2011071799A2/en
Publication of WO2011071799A3 publication Critical patent/WO2011071799A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Provided are processes for the purification of bivalirudin. Also provided is substantially pure bivalirudin.
PCT/US2010/059045 2009-12-11 2010-12-06 Purification of bivalirudin Ceased WO2011071799A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN3077/CHE/2009 2009-12-11
IN3077CH2009 2009-12-11
US31286510P 2010-03-11 2010-03-11
US61/312,865 2010-03-11

Publications (2)

Publication Number Publication Date
WO2011071799A2 WO2011071799A2 (en) 2011-06-16
WO2011071799A3 true WO2011071799A3 (en) 2011-10-27

Family

ID=44146122

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/059045 Ceased WO2011071799A2 (en) 2009-12-11 2010-12-06 Purification of bivalirudin

Country Status (1)

Country Link
WO (1) WO2011071799A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045503A1 (en) 2004-10-19 2006-05-04 Lonza Ag Method for solid phase peptide synthesis
CN104877024B (en) * 2015-06-29 2018-09-18 海南中和药业股份有限公司 A kind of purifying process of Angiomax bulk pharmaceutical chemicals
CN114965458B (en) * 2022-06-09 2024-12-31 昆明龙津药业股份有限公司 A quality detection method for bivalirudin raw material and its preparation
CN116087389B (en) * 2022-12-28 2023-11-10 江苏诺泰澳赛诺生物制药股份有限公司 HPLC determination method of bivalirudin related substances for injection
CN117088966A (en) * 2022-12-29 2023-11-21 江苏诺泰澳赛诺生物制药股份有限公司 Synthesis method of bivalirudin impurity

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070093423A1 (en) * 2005-09-14 2007-04-26 Avi Tovi Process for production of Bivalirudin
US20080051558A1 (en) * 2006-03-10 2008-02-28 Yiming Zhou Method of preparing bivalirudin
US20080287650A1 (en) * 2007-03-01 2008-11-20 Avi Tovi High purity peptides
US20090062511A1 (en) * 2007-09-05 2009-03-05 Raghavendracharyulu Venkata Palle Process for the preparation of bivalirudin and its pharmaceutical compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070093423A1 (en) * 2005-09-14 2007-04-26 Avi Tovi Process for production of Bivalirudin
US20080051558A1 (en) * 2006-03-10 2008-02-28 Yiming Zhou Method of preparing bivalirudin
US20080287650A1 (en) * 2007-03-01 2008-11-20 Avi Tovi High purity peptides
US20090062511A1 (en) * 2007-09-05 2009-03-05 Raghavendracharyulu Venkata Palle Process for the preparation of bivalirudin and its pharmaceutical compositions

Also Published As

Publication number Publication date
WO2011071799A2 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
SI2398785T1 (en) Purification of 1-s2-(2,4-dimethylphenylsulfanyl)phenylc-piperazine
ZA200905167B (en) Process for the purification of water
WO2010122578A3 (en) Process for preparation of sitagliptin and its intermediates
LT2504350T (en) Process for the purification of glycoproteins
GB2462234B (en) Process for the separation of diastereomers
GB0922623D0 (en) Methods for the purification of cucurbituril
WO2010028122A8 (en) Process for making bivalirudin
ZA201104195B (en) Process for the production of bivalirudin
EP2632879A4 (en) Process for the production of purified xylene isomers
IL216942A0 (en) Process for the manufacture of alkenones
PL2022504T3 (en) Ointment for the treatment of haemorrhoids
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
WO2011071799A3 (en) Purification of bivalirudin
WO2013072933A3 (en) Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide
EP2300400A4 (en) Process for the production and purification of propylene glycol
EP2516412A4 (en) Processes for the purification of lubiprostone
ZA201100752B (en) Process for the purification of methanol by distillation
EP2275423B8 (en) Process for the synthesis of paliperidone
WO2011132045A3 (en) Process for the preparation of dienogest substantially free of impurities
AU330568S (en) Steering wheel
HK1170235A (en) Process for the preparation of cathepsin s inhibitors
HK1166856A (en) Use of cathepsin h
AU2009903544A0 (en) Wastewater Treatment Process
AU2009903826A0 (en) No Wheel Walker
HK1163531A (en) Compound for the treatment of tuberculosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10836467

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 6034/CHENP/2012

Country of ref document: IN

122 Ep: pct application non-entry in european phase

Ref document number: 10836467

Country of ref document: EP

Kind code of ref document: A2